6 results

• Aloprim, Zyloprim Should Be Stopped at First Sign of Stevens-Johnson Syndrome, Study Warns

  July 29, 2024

  Irvin Jackson

  A review of cases of Aloprim and Zyloprim-initiated Stevens-Johnson Syndrome results in researchers urging doctors to remove patients from the gout drugs immediately at the first sign of hypersensitivity.

• Uloric Benefits Do Not Outweigh Heart Risks For Most Patients, FDA Panel Determines

  January 15, 2019

  Martha Garcia

  FDA advisors call for Uloric to be a second-line gout treatment, saying the heart risks are too dangerous for most patients.

• Study Finds No Link Between Zyloprim and Kidney Disease

  October 12, 2018

  Irvin Jackson

  A new study suggests that Zyloprm and Aloprim side effects may provide some protection against chronic kidney disease, despite concerns to the contrary.

• Uloric May Carry Risk of Fatal Heart Problems: Study

  March 15, 2018

  Irvin Jackson

  A new study warns that the side effects of Uloric may incrase the risk of death due to cardiovascular problems when compared to competing gout medications.

• Uloric Side Effects May Increase Risks of Heart-Related Death, FDA Warns

  November 16, 2017

  Irvin Jackson

  The FDA has launched an investigation into the side effects of Uloric after safety signals indicated it could increase the risk of cardiovascular deaths.

• Side Effects of Allopurinol Drugs for Gout Linked to Risk of SJS, Other Hypersensitivity Reactions

  July 22, 2015

  Irvin Jackson

  A new study warns that hypersensitivity reactions to some drugs may cause fatal cases of Stevens-Johnson Syndrome and toxic epidermal necrolysis.